-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On October 18, the State Food and Drug Administration held a work report meeting for regulatory scientific research bases to listen to the progress of the work and research results of each base, exchange work experience, and deploy the next key work
.
Jiao Hong, director of the State Food and Drug Administration, attended and spoke at the meeting, and Xu Jinghe, Zhao Junning, Huang Guo, deputy directors of the State Food and Drug Administration, and the director of drug safety attended the meeting
.
The meeting was chaired
by Zhao Junning, deputy director of the State Food and Drug Administration.
Since the launch and implementation of the China Drug Regulatory Science Action Plan in April 2019, the NMPA has successively built 14 regulatory scientific research bases relying on the Chinese Academy of Medical Sciences, Sichuan University, China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, South China University of Technology, Beijing Technology and Business University, etc.
, through various methods, covering the fields of
drugs, medical devices and cosmetics 。 At the meeting, the main responsible comrades of each regulatory scientific research base introduced the progress and plans of the bases in helping to develop new tools, new standards and new methods, serving regulatory needs, promoting the construction of regulatory science disciplines and talent training, and discussed
the in-depth scientific research on drug regulation.
Jiao Hong fully affirmed the work results of
supervising the scientific research base.
She said that under the guidance and support of the State Food and Drug Administration and the active participation of experts from all parties, each base has actively promoted research work, produced a series of new regulatory tools, new standards and new methods, and made progress
in the construction of regulatory science disciplines, talent training and international exchanges.
Regulatory scientific research will lay a solid foundation and provide support for the improvement of regulatory level and high-quality development of the industry, and relevant work
should continue to be promoted in depth.
Jiao Hong deployed
the key points of supervision and scientific research base in the next step.
First, improve the mechanism and collaborate on innovation
.
All bases should establish a close cooperation mechanism with all departments and bureaus and directly under the State Food and Drug Administration, strengthen communication, work coordination and achievement sharing, uphold an open and cooperative attitude, and encourage the active participation
of industrial and industry forces.
Second, scientific planning and highlighting key points
.
Each base should carry out long-term planning, closely follow the international frontier, base on the national innovation-driven development strategy, combine the needs of supervision and industrial needs, highlight its own characteristic advantages, and strengthen the coordination between bases to enhance the forward-looking, scientific and systematic nature of regulatory scientific research
.
Third, strengthen exchanges and cooperation
.
It is necessary to build a platform, closely communicate work and experience, coordinate the resources of government, industry, academia and research, and deepen domestic and international academic exchanges and research cooperation
.
The fourth is to promote the high-quality development of
the industry.
It is necessary to actively promote the transformation and application of research results, promote the improvement of drug supervision capabilities, innovate and develop high-quality services to better meet the needs of
public health.
The meeting stressed that the general secretary proposed in the report to accelerate the implementation of the innovation-driven development strategy
.
Fully promoting scientific research on drug supervision is an important measure
taken by the State Food and Drug Administration to implement the deployment of the Party Central Committee and the State Council and strengthen regulatory capacity building through scientific and technological support.
It is necessary to adhere to problem-oriented and demand-oriented, increase support and guarantees, deeply promote regulatory scientific research, strive to create a scientific system of drug supervision with Chinese characteristics, promote the modernization of the drug supervision system and regulatory capacity, accelerate the leap from a pharmaceutical country to a pharmaceutical power, and contribute Chinese wisdom and strength
to the development of international drug regulatory science.
The main responsible comrades and relevant personnel of the State Food and Drug Administration's regulatory scientific research base, relevant departments and bureaus of the State Food and Drug Administration, and the China Drug Regulatory Research Association attended the meeting
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). 
